Holocene Advisors’s Akero Therapeutics AKRO Stock Holding History

Holocene Advisors’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,055,186	Closed	-$50.1M	–	738
2025 Q3	$50.1M	Sell	1,055,186 -20,456	-2%	-$991K	0.11%	172
2025 Q2	$57.4M	Buy	+1,075,642	New	+$48.9M	0.14%	154
2023 Q4	–	Sell	-21,873	Closed	-$431K	–	686
2023 Q3	$1.11M	Buy	+21,873	New	+$1.02M	﹤0.01%	629

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Holocene Advisors's AKRO Position: Q4 2025 in Review

Holocene Advisors sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 1,055,186 shares — an estimated $50.1M sold.

Holocene Advisors first reported a position in AKRO in Q3 2023 and held it in 3 quarters. The position peaked at $57.4M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Holocene Advisors reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Holocene Advisors sold 1,055,186 Akero Therapeutics shares in Q4 2025, an estimated $50.1M.
Holocene Advisors first reported a position in Akero Therapeutics in Q3 2023 and held it in 3 quarters.
Holocene Advisors's Akero Therapeutics position peaked at $57.4M in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Holocene Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.